论文部分内容阅读
目的:探讨重度癌痛综合治疗中经皮自控镇痛(PCSA)的临床作用。方法:利用PCSA止痛的即时性,止痛效价高于口服,对吗啡滴定作用的特点。针对不能通过口服吗啡有效控制的33例重度癌痛患者,观察在综合治疗过程中PCSA的止痛效果,以及综合治疗之后在止痛维持方面,应用PCSA进行口服吗啡止痛或硬膜外自控镇痛的选择。结果:33例重度癌痛患者,综合治疗中全部能有效止痛。29例重新应用口服硫酸吗啡控释片止痛,余4例应用硬膜外自控镇痛泵镇痛。结论:PCSA使重度癌痛综合治疗更完善。
Objective: To investigate the clinical effect of percutaneous controlled analgesia (PCSA) in the treatment of severe cancer. Methods: The use of PCSA analgesic immediate, analgesic potency higher than oral, morphine titration characteristics. To evaluate the analgesic effect of PCSA during the comprehensive treatment for 33 patients with severe cancer who can not be effectively controlled by oral morphine, and to choose PCSA for oral analgesia or epidural-controlled analgesia in terms of analgesic maintenance after comprehensive treatment . Results: 33 patients with severe cancer pain, comprehensive treatment can effectively relieve pain. 29 cases of re-application of oral morphine sulfate controlled release tablets analgesic, the other 4 cases of epidural analgesic pump with analgesia. Conclusion: PCSA makes the comprehensive treatment of severe cancer pain more perfect.